Tizanidine for spasticity.
D000284:Administration, Oral; D000316:Adrenergic alpha-Agonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D003000:Clonidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006801:Humans; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009128:Muscle Spasticity / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
D000316:Adrenergic alpha-Agonists; D009125:Muscle Relaxants, Central; C023754:tizanidine; D003000:Clonidine